Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Multiple insights from myogenic cell transplants.

Partridge TA, Morgan JE.

Hum Gene Ther. 2014 May;25(5):404-5. doi: 10.1089/hum.2014.035. No abstract available.

PMID:
24848316
2.

Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase.

Quenneville SP, Chapdelaine P, Rousseau J, Tremblay JP.

Gene Ther. 2007 Mar;14(6):514-22. Epub 2006 Nov 30.

PMID:
17167499
3.

First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up.

Skuk D, Goulet M, Roy B, Piette V, Côté CH, Chapdelaine P, Hogrel JY, Paradis M, Bouchard JP, Sylvain M, Lachance JG, Tremblay JP.

Neuromuscul Disord. 2007 Jan;17(1):38-46. Epub 2006 Dec 4.

PMID:
17142039
4.

Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.

Rousseau J, Dumont N, Lebel C, Quenneville SP, Côté CH, Frenette J, Tremblay JP.

Cell Transplant. 2010;19(5):589-96. doi: 10.3727/096368910X4863235.

PMID:
20650035
5.

Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.

Rouger K, Larcher T, Dubreil L, Deschamps JY, Le Guiner C, Jouvion G, Delorme B, Lieubeau B, Carlus M, Fornasari B, Theret M, Orlando P, Ledevin M, Zuber C, Leroux I, Deleau S, Guigand L, Testault I, Le Rumeur E, Fiszman M, Chérel Y.

Am J Pathol. 2011 Nov;179(5):2501-18. doi: 10.1016/j.ajpath.2011.07.022. Epub 2011 Sep 13.

6.

Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cells.

Chaouch S, Mouly V, Goyenvalle A, Vulin A, Mamchaoui K, Negroni E, Di Santo J, Butler-Browne G, Torrente Y, Garcia L, Furling D.

Hum Gene Ther. 2009 Jul;20(7):784-90. doi: 10.1089/hum.2008.163.

PMID:
19358679
7.

Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability.

Gonçalves MA, van Nierop GP, Tijssen MR, Lefesvre P, Knaän-Shanzer S, van der Velde I, van Bekkum DW, Valerio D, de Vries AA.

J Virol. 2005 Mar;79(5):3146-62.

8.

Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells.

Skuk D, Goulet M, Roy B, Chapdelaine P, Bouchard JP, Roy R, Dugré FJ, Sylvain M, Lachance JG, Deschênes L, Senay H, Tremblay JP.

J Neuropathol Exp Neurol. 2006 Apr;65(4):371-86.

PMID:
16691118
9.

Fetal muscle-derived cells can repair dystrophic muscles in mdx mice.

Auda-Boucher G, Rouaud T, Lafoux A, Levitsky D, Huchet-Cadiou C, Feron M, Guevel L, Talon S, Fontaine-Pérus J, Gardahaut MF.

Exp Cell Res. 2007 Mar 10;313(5):997-1007. Epub 2007 Jan 10.

PMID:
17275812
10.

Nuclear and nuclear envelope localization of dystrophin Dp71 and dystrophin-associated proteins (DAPs) in the C2C12 muscle cells: DAPs nuclear localization is modulated during myogenesis.

González-Ramírez R, Morales-Lázaro SL, Tapia-Ramírez V, Mornet D, Cisneros B.

J Cell Biochem. 2008 Oct 15;105(3):735-45. doi: 10.1002/jcb.21870.

PMID:
18680104
11.
12.

Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle.

Gibson AJ, Karasinski J, Relvas J, Moss J, Sherratt TG, Strong PN, Watt DJ.

J Cell Sci. 1995 Jan;108 ( Pt 1):207-14.

13.

Myogenic potential of adipose-tissue-derived cells.

Di Rocco G, Iachininoto MG, Tritarelli A, Straino S, Zacheo A, Germani A, Crea F, Capogrossi MC.

J Cell Sci. 2006 Jul 15;119(Pt 14):2945-52.

14.

Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells.

Gonçalves MA, Holkers M, Cudré-Mauroux C, van Nierop GP, Knaän-Shanzer S, van der Velde I, Valerio D, de Vries AA.

Mol Ther. 2006 May;13(5):976-86. Epub 2006 Jan 26.

15.

Cells of extraembryonic mesodermal origin confer human dystrophin in the mdx model of Duchenne muscular dystrophy.

Kawamichi Y, Cui CH, Toyoda M, Makino H, Horie A, Takahashi Y, Matsumoto K, Saito H, Ohta H, Saito K, Umezawa A.

J Cell Physiol. 2010 Jun;223(3):695-702. doi: 10.1002/jcp.22076.

PMID:
20162617
16.

Strand bias in oligonucleotide-mediated dystrophin gene editing.

Bertoni C, Morris GE, Rando TA.

Hum Mol Genet. 2005 Jan 15;14(2):221-33. Epub 2004 Nov 24.

PMID:
15563511
17.

In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells.

Muguruma Y, Reyes M, Nakamura Y, Sato T, Matsuzawa H, Miyatake H, Akatsuka A, Itoh J, Yahata T, Ando K, Kato S, Hotta T.

Exp Hematol. 2003 Dec;31(12):1323-30. Erratum in: Exp Hematol. 2008 Aug;36(8):1055.

PMID:
14662341
18.

Gene complementation using myoblast transfer into fetal muscle.

Sopper MM, Hauschka SD, Hoffman E, Ontell M.

Gene Ther. 1994 Mar;1(2):108-13.

PMID:
7584065
19.

Efficient conversion of ES cells into myogenic lineage using the gene-inducible system.

Ozasa S, Kimura S, Ito K, Ueno H, Ikezawa M, Matsukura M, Yoshioka K, Araki K, Yamamura KI, Abe K, Niwa H, Miike T.

Biochem Biophys Res Commun. 2007 Jun 15;357(4):957-63. Epub 2007 Apr 17.

PMID:
17466266
20.

Losartan enhances the success of myoblast transplantation.

Fakhfakh R, Lamarre Y, Skuk D, Tremblay JP.

Cell Transplant. 2012;21(1):139-52. doi: 10.3727/096368911X576045. Epub 2011 Apr 29.

PMID:
21535912

Supplemental Content

Support Center